Literature DB >> 10600730

Synergy and duality in peptide antibiotic mechanisms.

D G McCafferty1, P Cudic, M K Yu, D C Behenna, R Kruger.   

Abstract

The molecular mechanisms by which peptide antibiotics disrupt bacterial DNA synthesis, protein biosynthesis, cell wall biosynthesis, and membrane integrity are diverse, yet historically have been understood to follow a theme of one antibiotic, one inhibitory mechanism. In the past year, mechanistic and structural studies have shown a rich diversity in peptide antibiotic mechanism. Novel secondary targeting mechanisms for peptide antibiotics have recently been discovered, and the mechanisms of peptide antibiotics involved in synergistic relationships with antibiotics and proteins have been more clearly defined. In apparent response to selective pressures, antibiotic-producing organisms have elegantly integrated multiple functions and cooperative interactions into peptide antibiotic design for the purpose of improving antimicrobial success.

Mesh:

Substances:

Year:  1999        PMID: 10600730     DOI: 10.1016/s1367-5931(99)00025-3

Source DB:  PubMed          Journal:  Curr Opin Chem Biol        ISSN: 1367-5931            Impact factor:   8.822


  31 in total

1.  Synergy with rifampin and kanamycin enhances potency, kill kinetics, and selectivity of de novo-designed antimicrobial peptides.

Authors:  Aparna Anantharaman; Meryam Sardar Rizvi; Dinkar Sahal
Journal:  Antimicrob Agents Chemother       Date:  2010-02-22       Impact factor: 5.191

2.  In vitro activities of tritrpticin alone and in combination with other antimicrobial agents against Pseudomonas aeruginosa.

Authors:  Oscar Cirioni; Andrea Giacometti; Carmela Silvestri; Agnese Della Vittoria; Alberto Licci; Alessandra Riva; Giorgio Scalise
Journal:  Antimicrob Agents Chemother       Date:  2006-08-28       Impact factor: 5.191

3.  In vitro activity of aurein 1.2 alone and in combination with antibiotics against gram-positive nosocomial cocci.

Authors:  Andrea Giacometti; Oscar Cirioni; Alessandra Riva; Wojciech Kamysz; Carmela Silvestri; Piotr Nadolski; Agnese Della Vittoria; Jerzy Łukasiak; Giorgio Scalise
Journal:  Antimicrob Agents Chemother       Date:  2007-01-12       Impact factor: 5.191

4.  Efficacy of tachyplesin III, colistin, and imipenem against a multiresistant Pseudomonas aeruginosa strain.

Authors:  Oscar Cirioni; Roberto Ghiselli; Carmela Silvestri; Wojciech Kamysz; Fiorenza Orlando; Federico Mocchegiani; Fabio Di Matteo; Alessandra Riva; Jerzy Lukasiak; Giorgio Scalise; Vittorio Saba; Andrea Giacometti
Journal:  Antimicrob Agents Chemother       Date:  2007-04-02       Impact factor: 5.191

5.  A crystal structure of a dimer of the antibiotic ramoplanin illustrates membrane positioning and a potential Lipid II docking interface.

Authors:  James B Hamburger; Amanda J Hoertz; Amy Lee; Rachel J Senturia; Dewey G McCafferty; Patrick J Loll
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-03       Impact factor: 11.205

6.  Functional synergy between antimicrobial peptoids and peptides against Gram-negative bacteria.

Authors:  Nathaniel P Chongsiriwatana; Modi Wetzler; Annelise E Barron
Journal:  Antimicrob Agents Chemother       Date:  2011-08-22       Impact factor: 5.191

Review 7.  Antimicrobial peptides: modes of mechanism, modulation of defense responses.

Authors:  Mohammad Rahnamaeian
Journal:  Plant Signal Behav       Date:  2011-09

8.  The Alzheimer's disease-associated amyloid beta-protein is an antimicrobial peptide.

Authors:  Stephanie J Soscia; James E Kirby; Kevin J Washicosky; Stephanie M Tucker; Martin Ingelsson; Bradley Hyman; Mark A Burton; Lee E Goldstein; Scott Duong; Rudolph E Tanzi; Robert D Moir
Journal:  PLoS One       Date:  2010-03-03       Impact factor: 3.240

9.  Antibacterial activities of nisin Z encapsulated in liposomes or produced in situ by mixed culture during cheddar cheese ripening.

Authors:  R-O Benech; E E Kheadr; C Lacroix; I Fliss
Journal:  Appl Environ Microbiol       Date:  2002-11       Impact factor: 4.792

Review 10.  Synergy and contingency as driving forces for the evolution of multiple secondary metabolite production by Streptomyces species.

Authors:  Gregory L Challis; David A Hopwood
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-11       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.